Secondary Hormone Therapy for Castration-Resistant Prostate Cancer

被引：0
|
作者：
Taplin, Mary-Ellen [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
来源：
ONCOLOGY-NEW YORK | 2013年 / 27卷 / 05期
关键词：
INCREASED SURVIVAL; ANDROGEN RECEPTOR; ABIRATERONE; CHEMOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：371 / +
页数：3
相关论文
共 50 条
  • [1] Castration-Resistant Prostate Cancer-Hormone Therapy Redux
    Tolcher, Anthony W.
    Cooper, Josh
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1447 - 1449
  • [2] Androgen Deprivation Therapy and Secondary Hormone Therapy in the Management of Hormone-sensitive and Castration-resistant Prostate Cancer
    Saad, Fred
    Fizazi, Karim
    UROLOGY, 2015, 86 (05) : 852 - 861
  • [3] Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer
    Nakabayashi, Mari
    Werner, Lillian
    Oh, William K.
    Regan, Meredith M.
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    CLINICAL GENITOURINARY CANCER, 2011, 9 (02) : 95 - 103
  • [4] How should hormone therapy for castration-resistant prostate cancer be continued?
    Spahn, M.
    Krebs, M.
    UROLOGE, 2012, 51 (01): : 15 - +
  • [5] The possibilities and mechanisms of action of hormone therapy for castration-resistant prostate cancer
    Alekseev, B. Ya.
    Andrianov, A. N.
    ONKOUROLOGIYA, 2013, 9 (01): : 68 - 73
  • [6] Satraplatin for the therapy of castration-resistant prostate cancer
    Sonpavde, Guru
    Sternberg, Cora N.
    FUTURE ONCOLOGY, 2009, 5 (07) : 931 - 940
  • [7] Pathophysiology and therapy of castration-resistant prostate cancer
    Merseburger, A. S.
    Kuczyk, M. A.
    Wolff, J. M.
    UROLOGE, 2013, 52 (02): : 219 - 225
  • [8] Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer
    Ponholzer, Anton
    Loidl, Wolfgang
    Bektic, Jasmin
    Dorfinger, Karl
    Hruby, Stephan
    Jeschke, Klaus
    Kramer, Gero
    Krause, Steffen
    Ludvik, Georg
    Remzi, Mesut
    Roider, Michael
    Stoiber, Franz
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (3-4) : 156 - 163
  • [9] Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer
    Anton Ponholzer
    Wolfgang Loidl
    Jasmin Bektic
    Karl Dorfinger
    Stephan Hruby
    Klaus Jeschke
    Gero Kramer
    Steffen Krause
    Georg Ludvik
    Mesut Remzi
    Michael Roider
    Franz Stoiber
    Wiener klinische Wochenschrift, 2016, 128 : 156 - 163
  • [10] Differential use of chemotherapy and novel hormone therapy for castration-resistant prostate cancer
    Kamoto, Toshiyuki
    ANNALS OF ONCOLOGY, 2017, 28 : 45 - 45
12345